Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997–2016

Autor: Jakob R. Passweg, Helen Baldomero, Marc Ansari, Gabriela M. Baerlocher, Mario Bargetzi, Yves Chalandon, Michel A. Duchosal, Sabine Gerull, Tayfun Güngör, Jörg P. Halter, Dominik Heim, Urs Hess, Kurt Leibundgut, Stavroula Masouridi-Levrat, Antonia Müller, Gayathri Nair, Thomas Pabst, Christoph Renner, Adrian Schmidt, Georg Stussi, Grazia Nicoloso de Faveri, Urs Schanz, for the Swiss Blood Stem Cell Transplantation Group (SBST)

Publikováno v: Swiss Medical Weekly, Vol 148, Iss 0910 (2018)

In 1997, the Swiss Blood Stem Cell Transplantation Group (SBST) initiated a mandatory national registry for all haematopoietic stem cell transplants (HCTs) in Switzerland. As of 2016, after 20 years, information was available for 7899 patients who ha

Externí odkaz: https://doaj.org/article/c36c8bd0307b48e194437f606e771da4

Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS

Autor: Markus G. Manz, Harm Sinnige, Marie-Christiane Vekemans, Jürgen Kuball, Yves Chalandon, Dominik Heim, Lidwine W. Tick, Thomas Pabst, Peter E. Westerweel, Marjolein van der Poel, Dimitri Breems, Jeroen Janssen, Marie-Cecile Legdeur, Ine Moors, Carlos Graux, Rolf E. Brouwer, Wim Terpstra, Danielle van Lammeren-Venema, Dries Deeren, Johan Maertens, Okke de Weerdt, Peter A. von dem Borne, Marinus van Marwijk Kooy, Marten R. Nijziel, Arjan A. van de Loosdrecht, Mojca Jongen-Lavrencic, Mels Hoogendoorn, Florence Van Obbergh, Yvette van Norden, Anna Efthymiou, Bjørn-Tore Gjertsen, Georg Stussi, Gert J. Ossenkoppele, Margriet Oosterveld, Bart J. Biemond, Asiong Jie, Mario Bargetzi, Edo Vellenga, Marjolein van der Klift, Aurélie Jaspers, Saskia K. Klein, Olivier Spertini, Walter J.F.M. van der Velden, Urs Hess, Bob Löwenberg, Michael Gregor

Publikováno v: Cancers, vol. 13, no. 4, pp. 672
Cancers, Vol. 13, No 4 (2021) P. 672
Cancers
Volume 13
Issue 4
Cancers, 13
Janssen, J, Löwenberg, B, Manz, M, Bargetzi, M, Biemond, B, von dem Borne, P, Breems, D, Brouwer, R, Chalandon, Y, Deeren, D, Efthymiou, A, Gjertsen, B T, Graux, C, Gregor, M, Heim, D, Hess, U, Hoogendoorn, M, Jaspers, A, Jie, A, Jongen-Lavrencic, M, Klein, S, van der Klift, M, Kuball, J, van Lammeren-Venema, D, Legdeur, M C, van de Loosdrecht, A, Maertens, J, Kooy, M V M, Moors, I, Nijziel, M, van Obbergh, F, Oosterveld, M, Pabst, T, van der Poel, M, Sinnige, H, Spertini, O, Terpstra, W, Tick, L, van der Velden, W, Vekemans, M C, Vellenga, E, de Weerdt, O, Westerweel, P, Stüssi, G, van Norden, Y & Ossenkoppele, G 2021, ' Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with aml and high risk mds ', Cancers, vol. 13, no. 4, 672, pp. 1-11 . https://doi.org/10.3390/cancers13040672
Cancers, Vol. 13, no. 4, p. 672 [1-11] (2021)
Cancers, Vol 13, Iss 672, p 672 (2021)
Cancers, 13(4):672, 1-11. Multidisciplinary Digital Publishing Institute (MDPI)
Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; Borne, Peter von dem; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; ... (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4) MDPI AG 10.3390/cancers13040672
Cancers, 13, 4
Cancers, 13(4):672. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13(4):672. MDPI AG
CANCERS

Simple Summary Treatment results of acute myeloid leukemia (AML) in elderly patients are unsatisfactory. We investigated in an open label randomized phase II study whether addition of tosedostat, an aminopeptidase inhibitor, to intensive chemotherapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6c3557e55ce8459b851cd9c38536009
https://research.rug.nl/en/publications/b689d4dd-486c-4cc1-9c6b-e638c8aa76ce

Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98)

Autor: Reinhard Zenhäusern, Mathew Simcock, Alois Gratwohl, Urs Hess, Mario Bargetzi, Andreas Tobler

Publikováno v: Haematologica, Vol 93, Iss 9 (2008)

Externí odkaz: https://doaj.org/article/1fb391a8479f44da927cc9db0bef3d09

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

Autor: Michael Flasshove, Markus Pfirrmann, Susanne Saußele, Wolf-K. Hofmann, M. P. Kraus, Benjamin Hanfstein, Urs Hess, Rüdiger Hehlmann, R. Mahlberg, Martin C. Müller, Gabriela M. Baerlocher, Tim H. Brümmendorf, Manuel Barreto Miranda, Dominik Heim, Christoph Nerl, Dieter K. Hossfeld, B. Rendenbach, Alice Fabarius, Walter Verbeek, Hans-Jochem Kolb, K. Neben, Stefan W. Krause, Otto Prümmer, Joerg Hasford, Axel A. Fauser, Ulrike Proetel, C. Ploger, Andreas Hochhaus, Michael Lauseker

Publikováno v: Leukemia
Miranda, M B; Lauseker, M; Kraus, M-P; Proetel, U; Hanfstein, B; Fabarius, A; Baerlocher, Gabriela M.; Heim, D; Hossfeld, D K; Kolb, H-J; Krause, S W; Nerl, C; Brümmendorf, T H; Verbeek, W; Fauser, A A; Prümmer, O; Neben, K; Hess, U; Mahlberg, R; Plöger, C; ... (2016). Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia, 30(6), pp. 1255-1262. Nature Publishing Group 10.1038/leu.2016.20
Leukemia : normal and malignant hemopoiesis 30(6), 1255-1262 (2016). doi:10.1038/leu.2016.20

Leukemia : normal and malignant hemopoiesis 30(6), 1255-1262 (2016). doi:10.1038/leu.2016.20
Published by Nature Publ. Group, Basingstoke

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdf359914ba36d5dbd6e2b05080f4b28
http://europepmc.org/articles/PMC4895174

Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013

Autor: Anita Feller, Nicolas Bonadies, Mario Bargetzi, Yves Chalandon, Volker Arndt, Annatina Schnegg-Kaufmann, Alicia Rovó, Georg Stussi, Michael Gregor, Jakob Passweg, Markus G. Manz, Helen Baldomero, Urs Hess, Anna Efthymiou, Olivier Spertini

Publikováno v: Cancer Epidemiology, Vol. 52 (2018) pp. 55-62

Acute Myeloid Leukaemia (AML) is a rare and heterogeneous haematological malignancy with increasing incidence in the elderly. We performed a population-based, observational analysis of AML cases reported to the Cantonal Cancer Registries in Switzerla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f6bc7f3797ed31758628f7009983d5e
https://pubmed.ncbi.nlm.nih.gov/29223104